A population-based evaluation of cervical screening in the United States: 2008-2011

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 5, 2014, Pages 765-773

  Cuzick, Jack ^a   Myers, Orrin ^b   Hunt, William C ^c   Robertson, Michael ^c   Joste, Nancy E ^c   Castle, Philip E ^d   Benard, Vicki B ^e   Wheeler, Cosette M ^c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b Division of Epidemiology   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d Global Cancer Initiative   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; FEMALE; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; POPULATION RESEARCH; PRIORITY JOURNAL; SCREENING TEST; SQUAMOUS CELL CARCINOMA; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VACCINATION; WART VIRUS; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DIAGNOSIS; FOLLOW UP; MIDDLE AGED; PROGNOSIS; TIME; UTERINE CERVICAL NEOPLASMS; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; TIME FACTORS; UNITED STATES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84899720946     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0973     Document Type: Article

References (47)

1. Sasieni P, Cuzick J, Farmery E. Accelerated decline in cervical cancer mortality in England and wales. Lancet 1995;346: 1566-7.
2. Sasieni P, Cuzick J, Lynch-Farmery. Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The national co-ordinating network for cervical screening working group. Br J Cancer 1996;73: 1001-5.
3. Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of the cervix in England: evaluation based on routinely collected statistics. BMJ 1999;318: 904-8.
4. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organized screening programmes. Lancet 1987;1: 1247-49.
5. IARC Working Group. Cervix cancer screening. IARC Handbooks of Cancer Prevention, International Agency for Research on Cancer, World Health Organization. IARC Press 2005.
6. Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ. Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer 2000;113: 1005-9.
7. de Kok IM, van der Aa MA, van Ballegooijen M, Siesling S, Karim-Kos HE, van Kemenade FJ, et al. Working group output of the Netherlands cancer registry. Trends in cervical cancer in the Netherlands until 2007: has the bottom been reached? Int J Cancer 2011;128: 2174-81
8. Andrae B, Andersson TM,Lambert PC, Kemetli L, Silfverdal L, Strander B, et al. Screening and cervical cancer cure: population based cohort study. BMJ 2012;344:e900.
9. Macgregor JE, Campbell MK, Mann EM, Swanson KY. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. BMJ 1994;308: 1407-11.
10. Day NE. The epidemiological basis for evaluating different screening policies. IARC Sci Publ 1986;76: 199-212.
11. Sawaya GF, Sung HY, Kinney W, Kearney KA, Miller MG, Hiatt RA. Cervical cancer after multiple negative cytologic tests in long-term members of a prepaid health plan. Acta Cytol 2005;391-7.
12. Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, et al. Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. N Engl J Med 2003;3491501-9.
13. Miller MG, Sung HY, Sawaya GF, Kearney KA, Kinney W, Hiatt RA. Screening interval and risk of invasive squamous cell cervical cancer. Obstet Gynecol 2003;101: 29-37.
14. Sung HY, Kearney KA, Miller M, Kinney W, Sawaya GF, Hiatt RA. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan. Cancer 2000;88: 2283-9.
15. Viikki M, Pukkala E, Hakama M. Risk of cervical cancer subsequent to a positive screening cytology: follow-up study in Finland. Acta Obstet Gynecol Scand 2000;79: 576-9.
16. Viikki M, Pukkala E, Hakama M. Risk of cervical cancer after a negative Pap smear. J Med Screen 1999;6: 103-7.
17. Olesen F. A case-control study of cervical cytology before diagnosis of cervical cancer in Denmark. Int J Epidemiol 1988;17: 501-8.
18. Nielsen NH, Jensen H. Screening for cancer of the uterine cervix in Greenland. APMIS 1993;101: 290-4.
19. Celentano DD, Klassen AC, Weisman CS, Rosenshein NB. Cervical cancer screening practices among older women: results from the Maryland Cervical Cancer Case-Control Study. J Clin Epidemiol 1988;41: 531-41.
20. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52: 342-62.
21. ACOG Practice Bulletin: clinical management guidelines for obstetrician- gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol 2003;102: 417-27.
22. Screening for cervical cancer: recommendations and rationale. Am Fam Physician 2003;67: 1759-66.
23. Wright TC Jr, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNAtesting as an adjunct to cervical cytology for screening. Obstet Gynecol 2004;103: 304-9.
24. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management ofwomen with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197: 346-55.
25. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management ofwomen with abnormal cervical screening tests. J Low Genit Tract Dis 2007;11: 201-22.
26. Moscicki AB, Cox JT. Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women. J Low Genit Tract Dis 2010;14: 73-80.
27. ACOG Committee on Practice Bulletins-Gynecology. ACOG Practice Bulletin no. 109: cervical cytology screening. Obstet Gynecol 2009;114: 1409-20.
28. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol 2012;137: 516-42.
29. Moyer VA. U.S. Preventive Services Task Force. Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012;156: 880-91, W312.
30. ACOG practice bulletin 131: screening for cervical cancer. Obstet Gynecol 2012;120: 1222-38.
31. Available from: http://www.nmcpr.state.nm.us/nmac/parts/title07/07.004. 0003.htm [accessed oncited 2013 Nov 4].
32. Available from: http://www.cdc.gov/cancer/npcr/. Version 2, 6/29/2007 [cited 2013 Nov 4].
33. Wheeler CM, Hunt WC, Cuzick J, Langsfeld E, Pearse A, Montoya GD, et al. A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination. Int J Cancer 2013;132: 198-207.
34. Available from: http://www.census.gov [cited 2012 Sep 26].
35. Centers for DiseaseControl and Prevention (CDC).Behavioral risk factor surveillance system survey data [cited 2013 May 4]. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2010. Available from: http://apps.nccd.cdc. gov/BRFSS/age.asp?cat= WH&yr=2010&qkey=4426&state=NM.
36. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287: 2114-9.
37. Habbema D, De Kok IM, Brown ML. Cervical cancer screening in the United States and the Netherlands: a tale of two countries. Milbank Q 2012;90: 5-37.
38. WilliamsWW, Lu PJ, Saraiya M, Yankey D, Dorell C, Rodriguez JL, et al. Factors associated with human papillomavirus vaccination among young adult women in the United States. Vaccine 2013;31: 2937-46.
39. Centers for Disease Control and Prevention (CDC). Cervical cancer screening among women aged 18-30 years - United States, 2000-2010. MMWR Morb Mortal Wkly Rep 2013;61: 1038-42.
40. Available from: http://seer.cancer.gov/statfacts/html/cervix.html [cited 2013 May 4].
41. Surveillance, Epidemiology, and End Results (SEER) Program (www. seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2011 Sub, Vintage 2009 Pops (2000-2009) - Linked To County Attributes - Total U.S., 1969-2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission.
42. Available from: http://www.cdc.gov/brfss/about.htm [cited 2013 May 4].
43. Ashok M, Berkowitz Z, Hawkins A, Tangka F, Sariaya M. Recency of Pap testing and future testing plans among women aged 18-64: analysis of the 2007 Health Information National Trends survey. J Women's Health 2012;21: 705-12.
44. Howard M, Agarwal G, Lytwyn A. Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis. Cancer Causes Control 2009;20: 1-13.
45. Myers JL. Why do young women get tested for sexually transmitted infections? Evidence from the National Longitudinal Study of Adolescent Health. J Womens Health (Larchmt) 2011;20: 1225-31.
46. Tao G, Hoover KW, Kent CK. Chlamydia testing patterns for commercially insured women, 2008. Am J Prev Med 2012;42: 337-41.
47. Plescia M, Richardson LC, Joseph D. New roles for public health in cancer screening. CA Cancer J Clin 2012;62: 217-9.